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Abstract
Mutations in the photoreceptor protein peripherin-2 (also known as RDS) cause severe reti-
nal degeneration. RDS and its homolog ROM-1 (rod outer segment protein 1) are synthe-
sized in the inner segment and then trafficked into the outer segment where they function in
tetramers and covalently linked larger complexes. Our goal is to identify binding partners of
RDS and ROM-1 that may be involved in their biosynthetic pathway or in their function in
the photoreceptor outer segment (OS). Here we utilize several methods including mass
spectrometry after affinity purification, in vitro co-expression followed by pull-down, in vivo
pull-down from mouse retinas, and proximity ligation assay to identify and confirm the
SNARE proteins Syntaxin 3B and SNAP-25 as novel binding partners of RDS and ROM-1.
We show that both covalently linked and non-covalently linked RDS complexes interact
with Syntaxin 3B. RDS in the mouse is trafficked from the inner segment to the outer seg-
ment by both conventional (i.e., Golgi dependent) and unconventional secretory pathways,
and RDS from both pathways interacts with Syntaxin3B. Syntaxin 3B and SNAP-25 are
enriched in the inner segment (compared to the outer segment) suggesting that the interac-
tion with RDS/ROM-1 occurs in the inner segment. Syntaxin 3B and SNAP-25 are involved
in mediating fusion of vesicles carrying other outer segment proteins during outer segment
targeting, so could be involved in the trafficking of RDS/ROM-1.
Introduction
Peripherin-2 also known as RDS (retinal degeneration slow) is an integral membrane tetraspa-
nin protein found in the rim region of the outer segment (OS) discs in rod and cone photore-
ceptors [1]. The OS is a modified cilium and proteins found in the OS are synthesized in an
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adjacent, but distinct, cellular compartment called the inner segment (IS). RDS is a structural
protein required for the formation of OSs, and mice homozygous for a naturally occurring
RDS null allele (rds-/- also known as rd2) do not form OSs and exhibit progressive photorecep-
tor degeneration [2]. In addition to its role as a structural protein, RDS also has membrane
fusogenic activity [3, 4], and the ability to induce membrane curvature [5]. Multiple different
RDS mutations cause widely varying forms of rod- and cone- dominant retinal diseases includ-
ing autosomal dominant retinitis pigmentosa and macular dystrophy in patients [6].
In the disc rim, RDS is tightly associated with ROM-1 (rod outer segment protein 1) a non-
glycosylated homolog with high structural similarity to RDS [7]. After synthesis, RDS and
ROM-1 form non-covalently linked homo- and heterotetramers. Subsequently, these core
complexes covalently link into higher-order complexes which are found in the OS [8, 9].
Assembly of these higher-order complexes involves the formation of an intermolecular disul-
fide bond mediated by C150. C150 is one of seven cysteines found in the second extracellular/
intradiscal (D2) loop of RDS and is the only D2 cysteine not involved in intramolecular inter-
actions [10, 11]. The importance of RDS/ROM-1 complex assembly is underscored by the
observation that many disease-causing-mutations alter complex formation [12, 13] and that
OSs fail to form in the absence of higher-order complexes (i.e. in the C150S transgenic mouse
on the rds-/- background) [10, 14].
Both our past research and the widely varying disease phenotypes in patients suggest that
RDS may function differently in rod vs. cone photoreceptors [6, 13, 15]. Though the reasons
for this are unclear, we have hypothesized that as yet unidentified binding partners of RDS/
ROM-1 complexes may play a role in the function of these proteins in photoreceptors. These
binding partners could interact with RDS/ROM-1 in a transient fashion, e.g. during OS target-
ing or at the base of the OS during disc assembly, or at the tip of the OS during the OS phagocy-
tosis process. Two known binding partners of RDS fall into this category, calmodulin and
melanoregulin, both of which are thought to regulate the fusogenic capability of RDS [16, 17].
Alternatively, interactions between RDS and its binding partners could be involved in more
long-term interactions in the OS, possibly to stabilize or regulate the structure of the OS. One
known RDS binding partner, the GARP/beta subunit of the rod cyclic nucleotide gated channel
(CNGβ) likely falls into this second category, and OS interactions between RDS and GARP/
CNGβ [18, 19] may be involved in linking adjacent OS rims or linking rims with the OS plasma
membrane.
Here, our goal was to identify novel RDS/ROM-1 interacting partners. Three members of
the SNARE family were identified, of which two (Syn3B and SNAP-25) were subsequently vali-
dated. These SNARE proteins are known to be involved in the trafficking of other OS integral




All animal handling, procedures, and maintenance were approved by the University of Okla-
homa Health Sciences Center Institutional Animal Care and Use Committee, and followed
guidelines set forth by the Association for Research in Vision and Ophthalmology. Animals were
reared on a 12H L/D cycle with maximum light intensity of ~30 lux. All mice were negative for
the rd8 allele. Retinas from the following mouse strains were used: WT (Jackson Laboratories,
Bar Harbor, ME), rds-/- (originally shared by Dr. Neeraj Agarwal, University of North Texas
Health Science Center, Fort Worth, TX), rom1-/- (shared by Dr. Roderick McInnes, University of
Toronto, Toronto, Canada), nrl-/- (shared by Dr. Anand Swaroop, National Eye Institute,
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Bethesda, MD), knock-in lines carrying a single point mutation in RDS (rdsY141C/Y141C [12],
rdsC150S/C150S and rdsN229S/N229S, generated for us by inGenious Targeting Laboratory, Ronkon-
koma, NY), and previously characterized transgenic mouse lines expressing mutant RDS on the
rds-/- or rds-/-/nrl-/- background (R172W/rds-/-, R172W/rds-/-/nrl-/- [13]). Animals were eutha-
nized at post-natal day (P) 30 for the current study and retinas were harvested as described previ-
ously [21].
Antibodies
Multiple antibodies for each protein were used and are indicated in the figure legends. Anti-
bodies are summarized in Table 1. For RDS, we used RDS-CT (rabbit polyclonal [21]) at
1:1,000 for western blot [WB] and immunofluorescence [IF], RDS 2E7 (mouse monoclonal,
generated by Precision Antibody) and RDS 2B7 (mouse monoclonal [13]), both used at 1:1,000
for WB and IF, and RDS-PCT1 (sheep polyclonal generously shared with us by Dr. Vadim
Arshavsky, Duke University, Chapel Hill, NC) at 1:1,000 for IF. For ROM-1, we used anti-
ROM-1 2H5 (mouse monoclonal [13]) at 1:5 for WB and 1:3 for IF, and ROM1-CT (rabbit
polyclonal [21]) at 1:1,000 for IF and WB, and ROM1-CT1 (sheep polyclonal generously
shared with us by Dr. Vadim Arshavsky, Duke University, Chapel Hill, NC) at 1:1,000 for IF.
Table 1. Antibodies Used.
Antigen Species Clone Source Cat. # Ref.
RDS Rabbit RDS-CT In house [21]
Mouse 2E7 Precision Antibody
Mouse 2B7 Precision Antibody [13]
Sheep RDS-PCT1 V. Arshavsky
ROM-1 Mouse 2H5 In house [13]
Rabbit ROM1-CT In house
Sheep ROM1-CT1 V. Arshavsky [21]
Syn3B Rabbit Synaptic Systems 110 032
Mouse 12E5 In House
Rabbit 478 R. Janz [22]
Rabbit 529 R. Janz
SNAP-25 Mouse Covance SMI-81R
Flag DDK Mouse OTI4C5 Origene TA50011
Flag DYKDDDDK Rabbit Cell Signaling 2368
VAMP-2 Mouse 69.1 Synaptic Systems 104 211
Cytochrome C Rabbit Cell Signaling 4272
Na+/K+-ATPase Mouse A5 Hybridoma Bank
Prominin-1 Rat 13A4 eBiosciences 14–1331
Rhodopsin Mouse 1D4 R. Molday [23]
Arrestin 1 Mouse E-3 Santa Cruz Biotechnology sc-166383
GARP/CNGB1 Mouse 4B1 R. Molday [18]
Actin Mouse AC-15 Sigma-Aldrich A3854
Rabbit IgG HRP Goat KPL 074–1506
Mouse IgG HRP Goat KPL 074–1807
Rabbit IgG 555 Donkey Life Technologies A-31572
Mouse IgG 488 Donkey Life Technologies R37114
Sheep IgG 488 Donkey Life Technologies A-11015
Rat IgG 594 Donkey Life Technologies A-21209
doi:10.1371/journal.pone.0138508.t001
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For Syn3B, we used anti-Syn3B-SySy (rabbit polyclonal, cat# 110 032, Synaptic Systems, Goettin-
gen, Germany) at 1:1,000, Syn3B-478 and Syn3B-529 (both rabbit polyclonal, a kind gift from
Dr. Roger Janz, University of Texas Medical School, Houston, TX) at 1:1,000, and Syn3B 12E5.
Syn3B 12E5 is a new mouse monoclonal generated in house and used at 1:1,000 for WB (S1 Fig).
We also used anti-SNAP-25 (cat# SMI-81R, mouse monoclonal, Covance, Princeton, NJ) at
1:1,000, anti-flag DDK (cat# TA50011, mouse monoclonal, Origene, Rockville, MD) at 1:1,000,
anti-flag DYKDDDDK (cat# 2368, rabbit polyclonal, Cell Signaling Technology, Danvers, MA)
at 1:1,000, anti-VAMP2 (mouse monoclonal, cat# 104 211, Synaptic Systems, Goettingen, Ger-
many) at 1:10,000 for WB and 1:1,000 for IF, and anti-Cytochrome C (rabbit polyclonal, cat#
4272, Cell Signaling, Danvers, MA) at 1:100 for IF, anti-Na+K+ATPase (mouse monoclonal, a5,
Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA) used at 1:500 for IF,
and anti-prominin-1 (rat, clone 13A4, eBiosciences, San Diego, CA) used at 1:1,000 for IF. The
a5 monoclonal antibody was developed by D.M. Fambrough, and was obtained from the Devel-
opmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The
University of Iowa, Department of Biology, Iowa City, IA 52242. Anti-rhodopsin (1D4, a mono-
clonal antibody) and anti-CNGB1/GARP (4B1 a monoclonal antibody) kind gifts fromDr. Rob-
ert Molday, University of British Columbia, Vancouver, Canada, and anti-arrestin 1 (mouse,
clone E-3, Santa Cruz Biotechnology, Dallas, TX) were used at 1:1,000 forWB. Anti-β-actin HRP
antibody (AC-15 monoclonal antibody, Sigma-Aldrich, St. Louis, MO) was used at 1:50,000 for
WB. Secondary antibodies were goat anti-mouse HRP and goat anti-rabbit HRP (KPL, Gaithers-
burg, MD), used at 1:25,000 for WB, and donkey anti-rabbit Alexafluor 555, donkey anti-mouse
Alexafluor 488, donkey anti-sheep Alexafluor 488 and donkey anti-rat Alexafluor 594 (Life Tech-
nologies, Grand Island, NY), both used at 1:1,000 for IF.
Proteomics
For LC-MS, 40 mouse retinas from either wild-type (WT) or rds-/- mice were homogenized by
passing through a series of needles ranging from 18G-26G, after suspending in homogenization
buffer containing 20 mM Tris-HCl, pH 7.2, 100 mMNaCl, 1 mMMgCl2 and protease inhibitor
(Roche Applied Sciences, Indianapolis, IN). Sucrose was added to a final concentration of 12%.
The extract was layered on top of a 50%/60% sucrose gradient and centrifuged at 43,000 x g for
40 min. The pellet was resuspended in homogenization buffer to dilute the sucrose and subse-
quently centrifuged at 32,000 x g. The pellet was then solubilized in buffer containing 20mM
HEPES, pH 7.5, 150mMNaCl, 5mM CHAPS, 0.55mM DTT and protease inhibitor (Roche
Applied Sciences, Indianapolis, IN) for 1h at 4°C. The protein extract was subjected to immu-
noprecipitation (IP) with antibodies against RDS, ROM-1, Syn3B, or IgG (control). For RDS
(2E7) and ROM-1 (2H5), antibodies were chemically linked to sepharose 2B beads and extracts
were incubated with beads for 1 h at 4°C. For the Syn3B and IgG, the protein was incubated
with the antibody (Synaptic Systems, Goettingen, Germany) and protein A beads overnight at
4°C. Elution was performed with a 1% SDS solution and was separated on SDS-PAGE. The
proteins were subjected to trypsin digestion in-gel (250 ng), extracted from the gel and freeze
dried. Analysis of the protein fragments was carried out by LC-MS (ESI-TRAP) by the Univer-
sity of Rochester Proteomics Center. Analysis of the peptide fragments was performed using
Scaffold 4 Proteomics software (Proteome Software Inc., Portland OR). The peptide fragments
were identified by using a subset of the NCBInr_20130830 database restricted to Mus musculus
and search engines Mascot and X!Tandem. Proteins were included in subsequent analysis if
their identity was established at a probability level of 95% or higher and at least one peptide
had been identified (Probability model Peptide prophet with Delta mass correction) [24, 25].
In addition, only proteins with a mascot score higher than 37 were considered as identified.
RDS/ROM-1 Interact with Syn3B and SNAP-25
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Vectors and Transient Transfections
Vectors containing WT ROM-1 cDNA, WT RDS cDNA, or RDS cDNA with the C150S muta-
tion under the control of the CMV promoter were generated by site-specific mutagenesis of the
previously characterized pCDNA3.1-RDS/ROM-1 vectors [26]. We acquired the pCMV6-syn-
taxin 3B and pCMV6-VAMP2-myc-DDK (Origene, Rockville, MD), which both contain a
CMV promoter and the cDNA sequence for Syn3B or VAMP2, respectively. The VAMP2
sequence was c-terminally tagged with flag (DDK) and Myc. The cDNA sequence for SNAP-
25 was acquired in pCMV-SPORT6-SNAP-25 with a CMV promoter (Thermo Scientific, Pitts-
burgh, PA). HEK293 cells grown in DMEM (Life Technologies, Grand Island, NY) with antibi-
otic/antimycotic solution (Corning Cellgro, Corning, NY) and 5% fetal bovine serum, were
transfected with equimolar amounts of the indicated vectors (~3.3μg/million cells, 1x106 cells
per 60.1 cm2 petri dish, covered with 2ml of medium). The DNA was added to 500 μl of a
250 mM CaCl2 solution and an equal amount of 2x BBS (50 mM BES, 280 mMNaCl, 1.4 mM
Na2HPO4, pH 6.96) was added while vortexing at 1700 rpm. The transfection mixture was
incubated at room temperature for 20 min and then added to the cells. The medium was
replaced after an overnight incubation, and cells were harvested after 48 h.
Immunoprecipitation (IP)
Retinas or cell extracts were quickly sonicated in 1x phosphate buffered saline (PBS, 137 mM
NaCl, 2.68 mM KCl, 1.47 mM KH2PO4, 8.1 Na2HPO4, pH 7.0) with 5 mM EDTA, 5 mg/ml
NEM (N-ethylmaleimide) and protease inhibitor (Roche Applied Sciences, Indianapolis, IN).
Either 2% Triton X-100 and 2.5% glycerol or 10 mM CHAPS was added as indicated in the
results. The retinal extract was solubilized at 4°C for 1 hour on a rocker and then centrifuged at
18,000 xg for 10 minutes. 100 μg of retinal extract (diluted to 0.5 μg/μl in 200 μl) (or 300 μg for
rdsY141C/Y141C and R172W/rds-/- and 500 μg for rdsC150/C150S and rds-/- to adjust for low levels of
RDS/ROM-1 in these lines) or 50 μg cell extract (diluted to 0.25 μg/μl in 200 μl) was incubated
for 2 h at 4°C in the presence of RDS-CT, ROM-1-CT, or Syn3B-478. Subsequently, protein A
sepharose beads (GE Healthcare, Pittsburgh, PA) were added for 1 h. The beads were washed
and eluted with 50 μl of a 1:1 mixture of the extraction buffer and 4x Laemmli buffer contain-
ing 400mMDTT. For non-reducing gels, the same buffer was used, but without DTT. For IPs
carried out using retinal extract, 7.5 μg (15 μl) of protein was loaded for the input and an equal
volume of the unbound fraction (15 μl, flow through). We loaded 65% of the bound fraction.
Western blots were performed using standard protocols and detection was performed with
HRP substrate (prepared after [27]) on a ChemiDocTM MP imager (Bio-Rad Laboratories Inc.,
Hercules, CA).
Glycosidase Treatment and Velocity Sedimentation
Non-reducing sucrose gradient velocity sedimentation was performed onWT and rom1-/- reti-
nal extracts as previously described [8, 13]. Retinal extracts (3 μg/sample for WT and 20 μg/
sample for rdsC150S/C150S) or gradient fractions (9 μl/fraction) were denatured for ten minutes
at 100°C using the denaturing buffer provided with the endoglycosidase H (EndoH)/PNGase F
(New England Biolabs, Ipswich, MA) in a total reaction volume of 30 μl. This was then sepa-
rated into 3 aliquots of 10 μl each and an additional 10 μl of enzyme master mix was added to
each sample for a final reaction volume of 20 μl. One of the three samples received EndoHmas-
ter mix (0.1 μl of EndoH plus manufacturer indicated buffer and water), the second sample
received PNGaseF master mix (1 μl PNGaseF plus manufacturer indicated buffer, detergent,
and water) and the third sample received mock master mix (EndoH buffer and water without
RDS/ROM-1 Interact with Syn3B and SNAP-25
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enzyme). All samples were then incubated at 37°C for two hours. Experiments were repeated
on 3–10 independent retinas/gradient fractions per group.
Immunofluorescence (IF)
Transfected HEK293 cells were fixed with cold methanol:acetone (80%:20%) for 20 minutes.
Cryosections were prepared from whole eyes fixed for 2h with 4% paraformaldehyde at 4°C
collected at post-natal day 30 and underwent IF as described previously [10]. Briefly, after
blocking in blocking buffer (1x PBS, pH 7.4, 1% fish gelatin, 2% donkey serum, 0.5% Triton X-
100, 50 mg/ml bovine serum albumin), sections or cells were incubated overnight in primary
antibodies in blocking buffer, followed by washing (4x 15 min with 1x PBS, pH 7.4), incubation
in appropriate fluorescently labeled secondary antibodies in blocking buffer, additional wash-
ing, and mounting using ProlongGold mounting media (Life Technologies). Sections with a
secondary antibody treatment only were used as a control to ensure the specificity of our anti-
bodies and to normalize for background autofluorescence. All sections were treated with a 1%
sodium borohydride solution for 2 min to minimize autofluorescence common in the retina.
Cells and sections were imaged using an Olympus BX62 upright microscope equipped with a
spinning disc confocal unit. Image analysis was performed using Slidebook v5 software (Intelli-
gent Imaging Innovations, Denver, CO).
Proximity Ligation Assay (PLA)
PLA assay was carried out using the Duolink1 In Situ kit (Olink Bioscience, Uppsala, Sweden)
on retinal cryosections. Antigen retrieval was carried out with methanol at -20°C for 20 min-
utes followed by several washing steps with water. The sections were treated with 1% sodium
borohydride for 2 minutes to quench tissue autofluorescence, washed with water and 1x PBS
and blocked for 90 minutes in blocking buffer (1xPBS, 1% fish gelatin, 2% donkey serum, 0.5%
Triton X-100 and 5% bovine serum albumin) at room temperature. Primary antibodies were
applied on sections in blocking buffer and incubated overnight at 4°C. After washing with 1x
PBS, the secondary antibodies (anti-rabbit and anti-mouse) provided with the kit were diluted
1:5 in blocking buffer and incubated on the sections for one hour at 37°C. After washing with
1x PBS, ligation stock from the kit was diluted 1:5 in water, ligase was added (1:40 dilution)
and incubated on the sections at 37°C for 30 minutes. Amplification stock from the kit was
diluted 1:5 with water and polymerase was added at a dilution of 1:160 before application on
the sections (washed with 1x Buffer A supplied with the kit after the ligation step) for 75 min-
utes at 37°C. After the final incubation step, sections are washed with 1x and 0.01x Buffer B
from the kit subsequently. Sections were mounted and analyzed as described above for IF using
filters for Texas Red. In each PLA experiment, paired sections underwent regular IF labeling
using the identical protocol (except with standard fluorescent secondary antibodies rather than
the PLA reagents) to confirm specificity of primary antibody labeling.
Results
Identification of Potential RDS/ROM-1 Interacting Partners
Our goal was to isolate RDS complexes and identify novel RDS/ROM-1 interacting partners.
For these studies, adult (postnatal day 30) WT mouse (Balb/C) retinal extracts were solubilized
using CHAPS since, of the four detergents we tested, CHAPS was the mildest (to maximize
identification of potential interacting partners) that still provided good RDS/ROM-1 solubiliza-
tion (S2 Fig). LC-MS analysis was performed using sepharose columns cross-linked to RDS
mAB 2E7 or ROM-1 mAB 2H5. As controls for the RDS and ROM-1 pulldowns, retinal
RDS/ROM-1 Interact with Syn3B and SNAP-25
PLOS ONE | DOI:10.1371/journal.pone.0138508 September 25, 2015 6 / 24
extracts from rds-/- animals were used. As expected, RDS was identified in the ROM-1 IP and
vice-versa (with high mascot scores). We also detected another known RDS binding partner,
CNGβ [18], in the RDS IP. We began our assessment of novel interacting partners by eliminat-
ing known contaminants (such as keratins). Proteins identified in the rds-/- group from the
RDS IP (blue, Fig 1A) were considered non-specific and were excluded. Although ROM-1
Fig 1. RDS/ROM-1 share interacting partners with each other and Syn3B. Euler diagrams depicting results from LC-MS studies to identify RDS/ROM-1
interacting partners. Numbers in each diagram represent proteins identified.A-B.WT and rds-/- retinal extracts were IPed using RDSmAB 2E7 (A) or ROM1
mAB 2H5 (B), cross-linked to sepharose followed by LC-MS. C. This diagram depicts overlap between proteins identified in RDS pull-down (A) and ROM-1
pull down (B) after subtraction of negative controls (blue circles A-B). D.WT retinal extracts were IPed with anti-Syn3B-SySy or IgG coupled to protein A
beads followed by LC-MS. E-F. These diagrams depict overlap between proteins in the RDS (E-left) or ROM-1 (E-right) IP and the Syn3B IP, or overlap
between all three (F).
doi:10.1371/journal.pone.0138508.g001
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levels are very low in rds-/- retinas, there is some ROM-1 present, so proteins which appeared
in the ROM-1 IP from rds-/- retinas (blue, Fig 1B) are not necessarily non-specific, but could
be ROM-1 binding partners which do not require RDS. However, they were excluded from fur-
ther analysis in this study as we were interested in components which interact with RDS or the
RDS/ROM-1 complex. After manually removing proteins found in the negative controls by
cross referencing the two lists, a substantial number of RDS and ROM-1 potential interacting
partners remained (green and yellow Fig 1A and 1B), and of these, the majority (54 proteins)
were common to the RDS and ROM-1 groups (Fig 1C).
Of the 54 proteins common to the RDS and ROM-1 groups, several were either SNARE or
SNARE-associated proteins or other proteins potentially involved in protein trafficking
(Table 2). SNAREs are known to play a role in targeting other proteins from the inner segment
to the OS, so for this study, we narrowed our focus to this category. Specifically, two proteins
identified by mass spectrometry (MS), Syntaxin 3 B (Syn3B) and synaptosomal-associated pro-
tein 25 (SNAP-25) are known to be involved in OS targeting of rhodopsin [28]. Syntaxin 3 has
four different isoforms (A-D), but only isoform B is expressed in the mouse retina [29].
Syn3B was selected as the first candidate for further study. We performed an IP on CHAPS-
extracted WT retinas using an antibody against Syn3B followed by LC-MS analysis as
described above. Knock-out animals for Syn3B are not available, so we used pull-down with
non-specific IgG as a negative control (Fig 1D). The IP with the Syn3B antibody pulled down a
Table 2. SNARE and Trafficking Telated Proteins Identified in MS Analysis.
Mascot Score








Syntaxin-binding protein 1 isoform a (Stxbp1,
Munc18-1)
NP_001107041.1 69 19% 371 202 147
V-type proton ATPase 116 kDa subunit (VPP1) NP_058616.1 96 12% 164 256
V-type proton ATPase subunit d 1 (Atp6v0d1) NP_038505 40 8% 125 161 246
V-type proton ATPase subunit E 1 (Atp6v1e1) NP_031536 26 12% 187 206 96
V-type proton ATPase catalytic subunit A (Atp6v1a) NP_031534 68 7% 81 65
vesicle-fusing ATPase (N-ethylmaleimide sensitive
factor, NSF)
NP_032766 83 5% 66 109
synaptic vesicle glycoprotein 2A (SV2A) NP_071313 83 9% 131 107
ras-related protein Rab-1B NP_083852 22 27% 182 121
ras-related protein Rab-3A NP_033027 25 25% 146 106
ras-related protein Rab-2A NP_067493 24 13% 102
synaptotagmin-1 isoform 2 NP_001239271 47 26% 374 351
vesicle-associated membrane protein-associated
protein A
NP_038961 28 12% 118 153
Vesicle transport through interaction with t-SNAREs
homolog 1B
NP_058080.2 27 14% 86
Syntaxin 1B NP_077725.1 33 21% 114 213
Syntaxin 6 NP_067408 29 9% 76
Syntaxin 12 NP_598648 31 33% 231
Synaptoporin NP_082328 31 15% 126
Synaptophysin NP_033331.2 33 13% 83
Vesicle-associated membrane protein 2 (Vamp2) NP_033523.1 13 35% 303 219 1104
synaptosomal-associated protein 25 (SNAP25) NP_035558 23 15% 63 465
Syntaxin-3 isoform B (Stx3) NP_001020478.1 33 8% 77 89 781
doi:10.1371/journal.pone.0138508.t002
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numerous proteins including several expected trafficking proteins as well as ROM-1 and RDS,
thus providing initial confirmation of an interaction between RDS/ROM-1 and Syn3B. Multi-
ple proteins overlapped between RDS/Syn3B and ROM-1/Syn3B pull-downs (Fig 1E) and a
few proteins were present in all three (Fig 1F). All trafficking proteins found in one of the IPs
(RDS/ROM-1/Syn3B) are summarized in Table 2.
Interaction of RDS and ROM-1 with Syn3B
To begin our validation of interactions between RDS/ROM-1 and Syn3B, we conducted recip-
rocal co-IP studies using transiently transfected HEK293 cells (which do not endogenously
express any of the proteins of interest). To facilitate detection of Syn3B along with RDS, we
generated and characterized a new monoclonal antibody (mAB 12E5) against Syn3B (S1 Fig).
This antibody gave a single band of the expected size in mouse and bovine retinal extracts and
in transiently transfected Syn3B in HEK293 cells (S1 Fig, left). No band was detected in
untransfected HEK293 cells, and all bands were indistinguishable from those obtained with
commercially available antibodies for Syn3B (S1 Fig, right). To study RDS/ROM-1/Syn3B
interactions, cells were co-transfected with vectors to express RDS and Syn3B or ROM-1 and
Syn3B. Transfection efficiency was relatively high (~60–70%) and immunocytochemistry con-
firmed that RDS/Syn3B and ROM-1/Syn3B were usually co-expressed (Fig 2A) in the double
transfected cells. After extraction with Triton-X 100, RDS and ROM-1 were both detectable in
the bound fraction of the respective Syn3B IPs (Fig 2B, right panels) suggesting a direct inter-
action between RDS and Syn3B as well as ROM-1 and Syn3B. This interaction was confirmed
by the reciprocal pull-down with RDS and ROM-1 (Fig 2B, left panels).
We have previously observed that RDS and ROM-1 do not form interactions when mixed
together post-extraction; a finding we attributed to the early assembly of RDS/ROM-1 com-
plexes in the ER and the fact that RDS/ROM-1 complexes occur within the same membrane.
In contrast, stable fusogenic SNARE complexes can form even in cell free systems [30, 31] or
post-extraction, consistent with the fact that these complexes are continually assembled and
disassembled in multiple distinct cellular compartments. To determine which category the
Syn3B/RDS interactions fell into, we single transfected HEK293 cells with RDS, ROM-1, or
Syn3B. Extracts from these cells were then mixed in a 1:1 ratio (based on total protein) and
subsequently IPed. As expected, RDS and ROM-1 failed to interact under these conditions (Fig
2C, left), while Syn3B and RDS did interact (Fig 2C, right). This suggests that RDS/Syn3B
likely do not initially (i.e. at the time of synthesis) assemble into a complex, but rather that the
RDS/Syn3B interaction occurs later.
The expression of proteins in cell culture to test their interaction is convenient, enabling
testing of individual pairs of proteins, but the setting is artificial. Overexpression of proteins in
culture can induce aggregation, and neither HEK293 cells nor any other tissue culture system
form elaborate structures like the OSs. Therefore, we next confirmed the interactions between
Syn3B/RDS and Syn3B/ROM-1 in vivo by using Triton-X 100 extracted WT retinas for the IPs.
The results closely mirrored the findings from the in vitro approach; Syn3B pulls down both
RDS and ROM-1 and vice-versa (Fig 3A). Interestingly, in both in vitro and in vivo experi-
ments, only a small fraction of RDS and ROM-1 interacts with Syn3B. Direct binding between
RDS/Syn3B and ROM-1/Syn3B was confirmed in vivo using retinal extracts from rds-/- and
rom1-/- animals (Fig 3B). To confirm that this binding was not due to non-specific interactions,
we assessed a panel of positive and negative control proteins. In IPs with Syn3B, only rhodop-
sin (assessed using monoclonal antibody 1D4, [23], and known to be trafficked via a Syn3B-
mediated pathway [20]) was detected in the bound fraction while several other OS (GARP,
arrestin 1) and IS/cell body (actin, Na+K+ATPase) proteins were detected only in the input and
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Fig 2. RDS and ROM-1 interact in vitrowith Syn3B. A-B. HEK293 cells were double transfected with RDS/Syn3B and ROM-1/Syn3B. A. IF of transfected
HEK293 cells demonstrating double transfection; RDS (RDS-CT) and ROM-1 (ROM1-CT) antibodies are shown in green, with Syn3B (mAB 12E5) antibody
in red. B. Transfected cell extracts underwent reciprocal co-IP with RDS (RDS-CT), ROM-1 (mAB 2H5), or Syn3B (Syn3B-478) antibodies, and resulting
WBs were probed for RDS (mAB 2B7), ROM-1 (mAB 2H5), or Syn3B (mAB 12E5) antibodies. C. HEK293 cells were single transfected with the indicated
plasmids and cell extracts were subsequently mixed in a 1:1 ratio prior to IP (same antibodies as in B). FT: flow-through.
doi:10.1371/journal.pone.0138508.g002
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flow through (Fig 3C). Similarly, rabbit and mouse IgG were used as negative controls, and no
Syn3B, ROM-1, or RDS was detected in the bound fraction with IgG pull-down (Fig 3D shows
a representative pull-down with rabbit IgG).
Consistent with previous findings, Syn3B is localized to the IS/cell body/synaptic layer (red,
Fig 3E, left and middle, synaptic layer not shown) [32], while most RDS and ROM-1 reside in
the OS. Interestingly, although RDS and ROM-1 are known to be synthesized in the IS and
present there for the duration of time needed to traffic to the OS, they are not routinely
detected in this compartment by us or others, [1, 21] with antibodies against either intracellular
or extracellular portions of the protein. This is likely due to the large quantity of RDS/ROM-1
in the OS vs. the relatively small amount being synthesized at any given time in the IS. Thus a
large region of co-localization visible by immunofluorescence between RDS/ROM-1 and
Fig 3. RDS and ROM-1 interact in vivowith Syn3B. A. Retinal extract fromWTmice underwent reciprocal co-IP for RDS (RDS-CT), ROM-1 (mAB 2H5),
and Syn3B (Syn3B-478 [22]) antibodies, andWB analysis was used to detect binding partners (RDS, mAB 2B7, ROM-1, mAB 2H5, Syn3B, mAB 12E5).B.
IPs were performed using ROM-1 mAB 2H5 and RDS-CT antibodies from retinal extract from rds-/- and rom1-/-mice, respectively. Blots were probed for RDS
(RDS-CT), ROM-1 (mAb 2H5) and Syn3B (mAb 12E5) antibodies. C. IP with anti-Syn3B (mAB 12E5) was performed onWT retinal extract and WBs were
probed with antibodies against rhodopsin (Rho), arrestin 1, GARP, Na+/K+-ATPase (ATPase) and actin. None of the tested proteins except rhodopsin was
detected after the pull down with Syn3B.D To ensure specificity of interactions, WT retinal extracts underwent IP with protein A beads and rabbit IgG.
Resulting blots were probed for RDS (mAB 2E7), ROM-1 (mAB 2H5), and Syn3B (mAB 12E5). FT: flow through. E. Distribution of RDS (RDS-CT, green),
ROM-1 (ROM1-CT, green middle, mAB 2H5, red right), and Syn3B (mAB 12E5, red) in the outer retina was assessed by IF, arrows show regions of co-
localization. F. Frozen retinal sections from at least 3 different WT eyes were co-labeled with RDS or ROM-1 (RDS-PCT1, ROM-1 mAB2H5, respectively) in
green, and Syn3B (Syn3B-529) in red and DAPI in blue and imaged at 100x. Shown are single planes from a confocal stack. Arrows indicate regions of co-
localization. Scale bar: 10 μm. OS: outer segment, IS: inner segment, ONL: outer nuclear layer.
doi:10.1371/journal.pone.0138508.g003
RDS/ROM-1 Interact with Syn3B and SNAP-25
PLOS ONE | DOI:10.1371/journal.pone.0138508 September 25, 2015 11 / 24
Syn3B in the IS would not be expected. However, we do observe a small region of overlap
between Syn3B and RDS (Fig 3E and 3F yellow, arrows) in the apical IS. This region of co-
localization can be observed more clearly at 100x; the right panel of Fig 3F shows single confo-
cal plane from a section co-labeled with RDS or ROM-1 (green) and Syn3B (red). We do not
observe a region of Syn3B/RDS co-labeling in all cells, suggesting the amount of overlap
between RDS and Syn3B varies from cell-to-cell and may depend on how much protein traf-
ficking is occurring in any given cell. In addition, since most RDS/ROM-1 synthesized in the IS
is not detected by standard IF, other approaches are needed to assess the extent of the
interaction.
Thus we turned to an alternative cell biological approach to study RDS/Syn3B and ROM-1/
Syn3b interactions in vivo: proximity ligation assay (PLA). This approach involves using sec-
ondary antibodies to which short oligonucleotides are conjugated. The subsequent ligation of a
fluorescently labeled third oligonucleotide which binds only if the two labeled proteins are in
very close proximity enables fluorescent detection of protein interacting partners [33]. Using
cryosections fromWT retinas, we performed paired experiments with PLA and IF. In Fig 4,
each image pair shows IF on the left (to confirm that antibodies were working, with colors cor-
responding to the labels above each image) and a corresponding PLA image on the right. In the
PLA image, if the proteins do not interact, no signal is detected, while red spots indicate areas
in which the two interacting proteins are found in close proximity. When we labeled with
RDS/Syn3B (Fig 4A, two representative images shown) substantial PLA signal was detected.
Although PLA labeling was less prominent with ROM-1/Syn3B it was still present (Fig 4B).
Fig 4. RDS/ROM-1/Syn3B interactions are visualized via PLA. PairedWT retinal cryosections underwent IF (left picture in each pair) or PLA (right picture
in each pair) for the indicated proteins. Label colors correspond with colors in IF. Red labeling in PLA indicates interaction between the two proteins. Nuclei
were stained with DAPI (blue). A-B. RDS/Syn3B (A) and ROM-1/Syn3B (B) interactions were assessed using RDSmAB 2E7, ROM-1 mAB 2H5, and Syn3B-
478 antibodies. Insets showmagnified regions.C-E. RDS/Cytochrome C (RDSmAB 2E7, Cyto-C polyclonal) served as a negative control (C) while positive
controls included RDS/ROM-1 [RDSmAB 2E7, ROM1-CT antibodies, (D)], and Syn3B/SNAP-25 [(Syn3B-478, SNAP-25 antibodies, (E)]. OS: outer
segments, IS: inner segments, ONL: outer nuclear layer. Scale bars, 10 μm.
doi:10.1371/journal.pone.0138508.g004
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No signal was detected in the negative control (Fig 4C, PLA performed using RDS and cyto-
chrome C, an unrelated IS protein). Positive controls included RDS/ROM-1 and Syn3B/SNAP-
25 (Fig 4D and 4E). RDS/Syn3B PLA signal is often concentrated at the apical IS (correspond-
ing to the periciliary region, arrows, Fig 4A), however signal is also detected in the rest of the IS
and cell body. PLA labeling throughout the IS and cell body is also found with Syn3B/ROM-1
(Fig 4B) RDS/ROM-1 (Fig 4D), and Syn3B/SNAP-25 (Fig 4E). This observation is consistent
with the idea Syn3B may interact with newly synthesized RDS and ROM-1 which are found in
the IS.
Interaction of RDS and ROM-1 with Other SNAREs
Having established that Syn3B interacts with RDS and ROM-1 we next examined other
SNAREs expressed in photoreceptors and identified in our RDS proteomics screen, namely
SNAP-25 and VAMP2. To validate potential interactions between RDS/ROM-1 and VAMP2,
we double transfected HEK293 cells with RDS or ROM-1 and VAMP2 (Fig 5A). In prelimi-
nary IP experiments in which cell extracts were solubilized with Triton X-100, VAMP2 was
not pulled down with RDS or ROM-1, but was abundant in the bound fraction after Syn3B
pull-down. Syn3B binding to VAMP2 is essential for vesicle fusion in synapses so this latter
result is expected [29]. Since our early experiments showed that the milder detergent CHAPS
still solubilized RDS/ROM-1, we repeated the double-transfection experiment but used
CHAPS to solubilize the proteins before the IP. Under these conditions, a small fraction of
VAMP2 was pulled down with both RDS and ROM-1 (Fig 5B). This is consistent with the pro-
teomics results, and suggests that binding of VAMP2 to RDS and ROM-1 is of a weaker nature
than the binding of RDS/ROM-1 to Syn3B. However, when we repeated the IPs using retinal
extracts, no VAMP2 was pulled down by RDS or ROM-1, even with solubilization in CHAPS
(Fig 5C). Although some other proteomic studies have identified VAMP2 in OS preparations
[34, 35], in distribution studies, both we and others detected VAMP2 primarily in the synaptic
layer (Fig 5D, green) rather than in the IS or OS. Combined, these data suggest that VAMP2
likely does not directly bind RDS/ROM-1 in the retina.
Finally, we assessed interactions between RDS/ROM-1 and SNAP-25, using both double
transfected cells (Fig 6A and 6B) and WT retinas (Fig 6C and 6D). Cell extracts were solubi-
lized in CHAPS and after IP with RDS, ROM-1, and Syn3B, SNAP-25 was detected in the
bound fractions (Fig 6B), indicating that the interaction between RDS/ROM-1 and SNAP-25
is direct and not mediated by Syn3B (no endogenous Syn3B is detected in HEK293 cells). This
interaction was also confirmed in vivo; IP of CHAPS extracted WT retinas with antibodies
against RDS or ROM-1 showed SNAP-25 in the bound fraction (Fig 6C). From this we con-
clude that RDS and ROM-1 interact not only with Syn3B but also with SNAP-25. As expected,
Syn3B and SNAP-25 also interacted in vivo (Fig 6C). In contrast to VAMP2, SNAP-25 (green,
Fig 6D) co-localizes with Syn3B (red, middle Fig 6D) in the IS of photoreceptor cells and thus
gives a similar distribution to Syn3B in reference to RDS (red, left Fig 6D) and ROM-1 (red,
right Fig 6D). These cell biological and biochemical data are consistent with the idea that
SNAP-25 interacts with newly synthesized RDS and ROM-1 in the IS.
Syn3B Interacts with Multiple RDS/ROM-1 Complex Types
Having confirmed that RDS and ROM-1 interact with members of the SNARE family, we next
asked what types of RDS/ROM-1 complexes are involved in these interactions. RDS and ROM-
1 initially assemble into non-covalently linked homo- and hetero-tetramers with subsequent
assembly into higher-order covalently linked complexes. These complexes are held together by
C150-mediated disulfide bonds in the D2 loop of RDS [8, 9]. Multiple RDS/ROM-1 complex
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Fig 5. VAMP2 shows a weak interaction with ROM-1 and RDS in vitro but not in vivo. A. HEK293 cells were co-transfected with vectors containing RDS,
ROM-1, or Syn3B and flag-tagged VAMP2 cDNA and fluorescently labeled for RDS (RDS-CT, red) ROM-1 (ROM1-CT, red), Syn3B (Syn3B-529, red), or
VAMP2 (anti-DDK, green) antibodies.B. CHAPS-solubilized cell extracts were used for IP with RDS (RDS-CT), ROM-1 (mAB 2H5), and Syn3B (mAB 12E5)
antibdoies, and resultant WBs were probed with RDS (mAB 2B7), ROM-1 (mAB 2H5), Syn3B (mAB 12E5), or VAMP2 (anti-DDK) antibodies.C. IP was
performed on CHAPS-solubilizedWT retinal extracts with the same antibodies as inB, and blots were probed for RDS (mAB 2B7), ROM-1 (mAB 2H5),
Syn3B (mAB 12E5), and VAMP2 (VAMP2-SySy) antibodies.D.WT retinal sections underwent IF for VAMP2 (VAMP2-SySy, green), and RDS (RDS-CT,
red), ROM-1 (ROM1-CT, red), or Syn3B (Syn3B-529, red) antibodies. Scale bars: 10 μm. OS: outer segment, IS: inner segment, ONL: outer nuclear layer.
FT: flow through.
doi:10.1371/journal.pone.0138508.g005
RDS/ROM-1 Interact with Syn3B and SNAP-25
PLOS ONE | DOI:10.1371/journal.pone.0138508 September 25, 2015 14 / 24
types are found in the OS: RDS/ROM-1 homo- and heterotetramers, RDS/ROM-1 homo- and
heteromeric intermediate sized disulfide linked oligomers, and large RDS homooligomers,
however, the different functions of these different complex types have not yet been elucidated.
To understand which type of RDS/ROM-1 complex (covalent or non-covalently linked)
Fig 6. RDS and ROM-1 interact directly with SNAP-25 in vitro and in vivo. A. HEK293 cells were co-transfected with SNAP-25 (green) and either RDS
(RDS-CT, red), ROM-1 (ROM1-CT, red) or Syn3B (Syn3B-529, red) antibodies. B. CHAPS-solubilized cell extracts underwent co-IP for RDS (RDS-CT),
Syn3B (mAB 12E5), and ROM-1 (mAB 2H5) antibodies. Resulting blots were probed for SNAP-25, RDS (mAB 2B7), Syn3B (mAB 12E5), or ROM-1 (mAB
2H5) antibodies. C. CHAPS-solubilizedWT retinal extract underwent IP and reducing SDS-PAGE/WB with the same antibodies as in B. D.WT retinal
sections underwent IF to study distribution of SNAP-25 (green) in the outer retina in relation to labeling with RDS (RDS-CT, red), Syn3B (Syn3B-529, red), or
ROM-1 (ROM1-CT, red) antibodies. Scale bars: 10 μm. OS: outer segment, IS: inner segment, ONL: outer nuclear layer. FT: flow through.
doi:10.1371/journal.pone.0138508.g006
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interact with Syn3B, we IPed with Syn3B fromWT retinal extract and eluted under non-reduc-
ing conditions. On non-reducing SDS-PAGE, the non-covalent RDS-RDS and RDS-ROM-1
interactions are interrupted by the SDS but the single C150-mediated intermolecular disulfide
bond is preserved. As a result, under non-reducing conditions, intermediate and higher-order
RDS complexes appear on western blots as a covalently bound dimer, while non-covalently
linked complexes show up as monomers. RDS eluted from the Syn3B IP was both monomeric
and dimeric (top, Fig 7A). Similarly, ROM-1 eluted from Syn3B IPs was both monomeric and
Fig 7. Syn3B associates with multiple types of RDS complexes. Protein extract fromWT (A) or rdsC150S/C150S (B) mouse retinas was IPed with anti-
Syn3B-478.A. Elution/SDS-PAGE was performed under non-reducing conditions. RDS (mAB 2B7) and ROM-1 (mAB 2H5) antibodies show two bands on
non-reducing western blot, monomers at around 37 kDa and dimers at around 75 kDa.B. Reducing SDS/PAGE after IP for RDS from rdsC150S/C150S retinal
extracts shows that oligomerization-incompetent RDS retains the ability to bind Syn3B. C. Extracts from HEK293 cells transfected with WT or C150S RDS
and Syn3B underwent IP for RDS (using RDSmAB 2E7 or RDS-CT) antibodies. Blots were subsequently probed for RDS (RDSmAB 2B7) or Syn3B (mAB
12E5) antibodies.D-G. Total retinal extracts (D, WT N = 10, rom1-/- N = 6, rdsC150S/C150S N = 3), fractions from non-reducing sucrose gradient velocity
sedimentations (E-F), or retinal extracts from Syn3B IP (G) underwent digestion with EndoH (H), PNGase F (F), or were undigested (mock, M). Results from
F are summarized graphically in E.
doi:10.1371/journal.pone.0138508.g007
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dimeric (bottom, Fig 7A). To confirm covalent linkage was not required for interactions
between RDS/Syn3B, we asked whether Syn3B could bind to C150S mutant RDS. This form of
RDS lacks the cysteine which is responsible for the formation of disulfide bonds between RDS
molecules, and as a result we and others have previously shown that it forms no covalently
linked complexes, and thus no dimers are present on western blots prepared under either
reducing or non-reducing conditions from either transgenic retinas or transfected cells [10,
11]. We conducted RDS IPs using knockin mice homozygous for the C150S mutation
(rdsC150S/C150S, Fig 7B) or HEK293 cells transfected with C150S-RDS (Fig 7C). We find that
C150S-RDS retains the ability to bind Syn3B (Fig 7B and 7C, bound) both in vivo and in tissue
culture, confirming that assembly of RDS into covalently linked complexes is not required for
RDS to bind to Syn3B.
Syn3B Interacts with Conventionally and Unconventionally Trafficked
RDS
Most transmembrane proteins which are synthesized in the IS traffic to the OS by a conven-
tional secretory pathway, i.e. through the trans-Golgi. However, recent work has shown that
RDS traffics through an unconventional pathway which bypasses the trans-Golgi [36]. Using a
ciliated cell line, it was demonstrated that blocking trans-Golgi mediated trafficking did not
block ciliary targeting of RDS, indicative of unconventional trafficking. Glycosylated proteins
that bypass the Golgi (specifically the medial Golgi where Golgi mannosidase II resides) remain
sensitive to endoglycosidase H (EndoH). Thus, EndoH sensitivity can be used as a marker for
conventional vs. unconventional trafficking of OS proteins, provided the protein in question
traffics properly to the OS and doesn’t accumulate in the ER (for example in cases of mis-
folded/degraded proteins). In keeping with this, RDS in both the cultured ciliated cells and
xenopus/bovine retinal extracts exhibited robust EndoH sensitivity [36]. Because a small por-
tion of RDS in the ciliated cells became EndoH resistant, suggesting a small fraction was pro-
cessed via the conventional secretory pathway, we wanted to investigate whether Syn3B
interacted with conventionally or unconventionally trafficked RDS.
First, we assessed what portion of RDS in the murine retina was trafficked via the conven-
tional vs. unconventional pathway. WT retinal extracts underwent digest with EndoH (Fig 7D,
lane E) or PNGaseF (Fig 7D, lane F, a positive control which removes all N-linked glycans) or
were mock digested (i.e. included all steps except addition of the enzyme, Fig 7D, lane M) fol-
lowed by western blotting. We find that 56.9% ± 5.5% of the total pool of RDS in the murine
retina is EndoH sensitive, with the rest remaining resistant, suggesting that in the mouse retina
some RDS traffics by both conventional and unconventional pathways. To ensure this outcome
was not due to incomplete digestion, we conducted the experiments with increasing amounts
of enzyme (up to 50x more than what was used in Fig 7D) without seeing any change in the
fraction digested.
We next asked whether different types of RDS complexes had differential sensitivity to
EndoH. WT retinal extracts underwent non-reducing velocity sedimentation on 5–20%
sucrose gradients to separate RDS/ROM-1 complexes. Previously we have observed that cova-
lently linked higher-order RDS homo-oligomers are found in fractions 1–3, intermediate sized
RDS/ROM-1 heteromeric complexes (both covalent and non-covalently linked) are found in
fractions 4–5 while heterotetramers are found in fractions 6–9 [8]. One gradient fraction repre-
senting each complex type (fractions 1, 5, and 8) then underwent glycosidase treatment (Fig
7E and 7F). We found that higher order RDS oligomers were completely EndoH sensitive,
while intermediate complexes exhibited mixed EndoH sensitivity and tetrameric complexes
were mostly EndoH resistant (Fig 7E and plotted in Fig 7F).
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Finally, to determine whether Syn3B binds RDS trafficked through both the conventional
and unconventional pathway, we conducted IP with Syn3B, and the eluents underwent EndoH
treatment followed by western blotting for RDS. We find that Syn3B binds to both EndoH sen-
sitive and EndoH resistant RDS (Fig 7G, bound lanes). This is consistent with our observation
that Syn3B binds both covalently linked (largely unconventionally trafficked) and non-cova-
lently linked (largely conventionally trafficked) RDS.
Mutant Forms of RDS Associated with Abnormal Complex Formation
Retain the Ability to Interact with Syn3B
Various RDS mutations in patients lead to different forms of retinal degeneration which can
affect rod- or cone-based vision (or both) and which can affect RDS/ROM-1 complex assem-
bly. We have also previously demonstrated that rods and cones have a differential requirement
for RDS and that some proteins such as the oligomerization-incompetent C150S protein, traffic
differently in rods vs. cones [10, 14]. As one of our long-term goals is to identify binding part-
ners that may contribute to these cell-type specific differences, we asked whether Syn3B could
bind RDS in cones. The photoreceptors in the WT mouse retina are 95–97% rods, so we uti-
lized retinal extracts from the nrl-/- knockout mouse retina (in which developing rods are con-
verted to cone-like cells [37]). IP for RDS from the nrl-/- showed that RDS in cones retains the
ability to bind Syn3B (Fig 8A).
Fig 8. Mutant RDS that retains the ability to target to the OS interacts with Syn3B. A-B. Retinal extracts fromWT and nrl-/- (A) or R172W transgenic and
Y141C knockin (B) underwent IP for RDS (using RDSmAB 2E7 or RDS-CT) antibodies. Blots were subsequently probed for RDS (RDSmAB 2B7) or Syn3B
(mAB 12E5) antibodies.
doi:10.1371/journal.pone.0138508.g008
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We were also interested in the ability of Syn3B to interact RDS mutants which cause abnor-
mal RDS/ROM-1 complex formation but not abnormal trafficking. The R172Wmutation in
RDS causes macular dystrophy [38] in patients and cone-dominant retinal degeneration in
mice [13, 21]. The transgenic R172W protein traffics correctly to the OS and does not accumu-
late in the IS in spite of the fact that it induces abnormalities in ROM-1 complex formation
[13]. We find that R172W-RDS retains the ability to bind Syn3B both on the rod (rds-/-) and
cone (rds-/-/nrl-/-) genetic backgrounds (top and middle, Fig 8B). We observe similar results
with retinas from Y141C knockin mice (rdsY141C/Y141C). The Y141C mutation causes pattern
dystrophy in patients [39] and rod and cone degeneration in knockin mice [12]. Y141C protein
forms highly abnormal covalently linked RDS/ROM-1 complexes, however it also traffics cor-
rectly to the OS and does not accumulate in the IS [12]. As in the case with R172W-RDS,
Y141C-RDS retains the ability to bind Syn3B (bottom Fig 8B). These results suggest that
though RDS/ROM-1 complexes assembly may be impaired to varying degrees by different
RDS mutations, provided the abnormal protein complexes properly target to the OS, they
retain the ability to bind Syn3B.
Discussion
Here we use multiple methods to demonstrate that Syn3B and SNAP-25 are novel interacting
partners for RDS and ROM-1. Syn3B and SNAP-25 are known to play a role in rhodopsin traf-
ficking to the OSs [20]. Syn3B and SNAP-25 are located on the IS plasma membrane (in addi-
tion to the synaptic terminals) which is where the fusion of rhodopsin vesicles is thought to
occur and the fusion of RDS- and ROM-1-bearing vesicles is predicted to occur. Given the
localization of Syn3B and SNAP-25 (i.e. they are excluded from the OS) and their known role
in trafficking and vesicle fusion, the most likely hypothesis to explain the role of Syn3B/RDS
interactions is that Syn3B and SNAP-25 are involved in the fusion of RDS/ROM-1 containing
vesicles in the IS. Experimental testing to elucidate the role of Syn3B/RDS interactions is a top
priority, but must await the development of a retina-specific conditional Syn3B knockout
mouse line since the global Syn3B knockout is embryonic lethal.
Syn3B is hypothesized to serve the same function for rhodopsin [20], i.e. mediating fusion
of rhodopsin containing vesicles during OS targeting. Since rhodopsin vesicles are not thought
to include RDS, it is possible that Syn3B-mediated vesicle fusion is a common component of
many different trafficking pathways. This hypothesis is supported by our observation that
Syn3B-bound RDS is both EndoH sensitive and EndoH resistant suggesting that both conven-
tionally (i.e. like rhodopsin) and unconventionally trafficked RDS [36] bind SNAREs. Interest-
ingly, we find that disease causing mutations which cause abnormalities in but do not abrogate
complex formation do not impair the ability of RDS to interact with Syn3B. This suggests that
while complex type may be a determinant of trafficking pathway, the type of complex formed
(tetrameric/oligomeric/abnormal) is not critical for interactions between RDS and Syn3B. The
observation that ROM-1 binds directly to Syn3B and SNAP-25 suggests that ROM-1 might be
capable of traveling to the OS without RDS. Although initial studies suggested this was unlikely
[40], more recent work has shown ROM-1 does not need RDS for OS targeting (although it
cannot support OS formation without RDS) [41, 42].
Every SNARE complex consists of at least two members (and usually more), a t-SNARE on
the target membrane and a v-SNARE on the membrane of the arriving vesicle. We identified
Syn3B as a candidate t-SNARE however; the only v-SNARE in our LC-MS analysis was
VAMP2. Although VAMP2 is in the retina and interacts with Syn3B [29, 34], it is not found in
substantial amounts in the IS or OS [32]. A prior proteomics study identified VAMP2 in OS
preparations [35], however fractionation methods for OSs have varying levels of purity and it is
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possible that VAMP2 might be contamination from another part of the retina, or might simply
be present at very low levels. Given that we were unable to confirm the interaction between
VAMP2 and RDS/ROM-1 in vivo, three formal possibilities exist. First, that VAMP2 is
involved in RDS vesicle fusion, but does not bind to RDS or ROM-1 directly. This is possible
since SNARE proteins do not necessarily bind to vesicular cargo; however the distribution of
VAMP2 in the retina makes it unlikely. The second possibility is that another v-SNARE or
VAMP is involved in RDS vesicle fusion, but that it also does not interact with RDS directly
and thus did not appear in our LC-MS results. A third possibility is that Syn3B-mediated RDS
vesicle fusion does not involve a v-SNARE. On the one hand, this seems unlikely; traditional
SNARE-mediated vesicle fusion is well-characterized and requires both a t- and v-SNARE and
RDS does not have a SNARE domain. However, RDS’ cytoplasmic C-terminal domain (already
thought to be the site of OS targeting sequences [40]) is multi-functional, contains an amphi-
pathic helix [5], and critically, the ability to mediate membrane fusion by unknown mecha-
nisms [3, 4]. Interestingly, the ability of RDS to mediate fusion events requires assembly of
RDS complexes, at least into tetramers, but possibly into larger covalently linked complexes,
since addition of reducing agents or impairment of tetramer assembly prevents or retards
fusion [4].
There is precedence for syntaxins to bind to non-SNARE partners involved in vesicular
transport, including vesicular cargoes such as vesicle coat proteins, tethering factors, and Rab
GTPases thought to be involved in regulating the targeting and docking of vesicles [43, 44]. In
addition, some syntaxins have been shown to bind proteins not involved in vesicular transport
such as ion channels, for example Syntaxin 1A binds to multiple subtypes of calcium channels
in the plasma membrane, an interaction required for voltage sensitive neurotransmitter release
[45, 46]. It is thus possible that direct binding between RDS and Syn3B/SNAP-25 means RDS
may play a role in the actual fusion event or determination of tethering with the targeted
membrane.
However, while it is possible that Syn3B-RDS interactions are a sign that Syn3B on the
plasma membrane is involved in fusion of RDS-containing vesicles with that membrane, it is
also possible that the interaction is a sign that the two proteins are actually trafficked together,
i.e. that newly synthesized Syn3B is packaged into RDS-containing vesicles. Further testing of
all these possibilities is required to understand the physiological roles of Syn3B/RDS/ROM-1
interactions and the role (if any) of RDS complex type in these processes.
Though our main goal in this study was to identify and verify novel RDS/ROM-1 binding
partners, our work investigating whether these newly identified binding partners interacted
with conventionally or unconventionally trafficked RDS brought to light interesting results
regarding the trafficking of different types of RDS complexes. Previous work has shown that
OS-depleted retinal extracts contain primarily RDS/ROM-1 tetramers, while OS-enriched reti-
nal extracts contain primarily covalently-linked higher order RDS complexes [8]. This has led
to the hypothesis that RDS assembles into tetramers in the IS and then traffics to the OS where
some of it further oligomerizes into homomeric large covalently linked complexes while the
rest remains in intermediate sized or tetrameric hetero-oligomers (with ROM-1). However,
our data here showing that different types of RDS complexes are preferentially trafficked by the
conventional vs. unconventional pathways indicate that the determination of RDS complex
type (i.e. large covalently linked complexes vs. non-covalently linked tetramers) is made prior
to or immediately after exit of newly synthesized RDS from the ER. This suggests that two dis-
tinct pools of RDS/ROM-1 are present from the time of initial synthesis, and that the final
complex composition (i.e. determination of which RDS is fated to be part of large homooligo-
mers vs. heterotetramers or intermediate complexes) is determined much earlier than the
arrival of the proteins in the OS. Since disease causing mutations can drastically alter the
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assembly of RDS complexes, future work will likely involve investigation of the role of the dif-
ferent types of RDS complexes.
Widely varying blinding disease phenotypes are associated with point mutations in RDS, and
these phenotypes have multiple different cellular/biochemical mechanisms [6, 47], many as yet
poorly understood. Thus, identifying proteins that bind to RDS and thus have the potential to
regulate its function, trafficking, or localization, is a critical goal. The trafficking of essential pro-
teins to the photoreceptor outer segment is a crucial point in the development and maintenance
of this specialized structure. In this study we are describing an interactions between RDS/ROM-1
and Syn3B and SNAP-25, two proteins well known for their function in vesicle fusion and pro-
tein trafficking. The same two proteins have been shown to be involved in the trafficking of rho-
dopsin and it is conceivable that they perform a similar function for RDS/ROM-1. It is therefore
possible that disruptions in the transport of either rhodopsin or RDS/ROM-1 would have a detri-
mental influence on the trafficking of the others. Rhodopsin tends to mislocalize in a variety of
retinal degeneration models, including the rds-/- [8, 41], and we have shown that in cones, opsins
mislocalized with some forms of mutant RDS [10, 14]. Further exploration of the potential for
abnormal trafficking to contribute to disease phenotypes will be a key part of studies designed to
understand molecular mechanisms for degeneration and the development of novel therapies.
The diversity of genes and mutations involved in retinal degeneration has always been a major
hurdle for successful treatment. The discovery of common pathological pathways shared by dif-
ferent proteins and diseases, possibly including trafficking abnormalities, could simplify the
development of new drugs and gene therapy vectors. Here we show that Syn3B and SNAP-25
bind multiple types of RDS/ROM-1 complexes, trafficked by both conventional and unconven-
tional pathways. Elucidation of the functional role of these interactions will be a key next step as
will evaluate additional RDS binding partners in rods vs. cones.
Supporting Information
S1 Fig. Characterization of monoclonal Syn3B antibody (12E5).Western blot incubated with
the monoclonal Syn3B antibody shows a band of the expected size of Syn3B in mouse and bovine
retinal extract, as well as in extracts from HEK293 cells transfected with a vector containing the
cDNA sequence of Syn3B. There is no detectable Syn3B in untransfected HEK293 cells.
(TIF)
S2 Fig. WT retinas were solubilized with the four detergents listed and supernatant (Sup)
and pellet (Pel) fractions were separated by SDS-PAGE. Resultant WBs were probed for RDS
(mAB 2B7) or ROM-1 (mAB 2H5) antibodies.
(TIF)
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